[HTML][HTML] Biased opioid ligands

A Faouzi, BR Varga, S Majumdar - Molecules, 2020 - mdpi.com
Achieving effective pain management is one of the major challenges associated with
modern day medicine. Opioids, such as morphine, have been the reference treatment for …

Designing safer analgesics via μ-opioid receptor pathways

HCS Chan, D McCarthy, J Li, K Palczewski… - Trends in …, 2017 - cell.com
Pain is both a major clinical and economic problem, affecting more people than diabetes,
heart disease, and cancer combined. While a variety of prescribed or over-the-counter …

Bifunctional opioid receptor ligands as novel analgesics

CW Cunningham, WM Elballa, SU Vold - Neuropharmacology, 2019 - Elsevier
Prolonged treatment of chronic severe pain with opioid analgesics is frought with
problematic adverse effects including tolerance, dependence, and life-threatening …

Targeting multiple opioid receptors–improved analgesics with reduced side effects?

T Günther, P Dasgupta, A Mann, E Miess… - British journal of …, 2018 - Wiley Online Library
Classical opioid analgesics, including morphine, mediate all of their desired and undesired
effects by specific activation of the μ‐opioid receptor (μ receptor). The use of morphine for …

Biased ligands at opioid receptors: Current status and future directions

T Che, H Dwivedi-Agnihotri, AK Shukla, BL Roth - Science signaling, 2021 - science.org
The opioid crisis represents a major worldwide public health crisis that has accelerated the
search for safer and more effective opioids. Over the past few years, the identification of …

[HTML][HTML] Mu opioid receptor heterodimers emerge as novel therapeutic targets: recent progress and future perspective

L Zhang, JT Zhang, L Hang, T Liu - Frontiers in pharmacology, 2020 - frontiersin.org
Opioids are the most effective analgesics used in the clinical management of cancer pain or
non-cancer pain. However, chronic opioids therapy can cause many side effects including …

Basic opioid pharmacology—an update

A James, J Williams - British journal of pain, 2020 - journals.sagepub.com
Opioids are a group of analgesic agents commonly used in clinical practice. The three
classical opioid receptors are MOP, DOP and KOP. The NOP (N/OFQ) receptor is …

Strategies towards safer opioid analgesics—A review of old and upcoming targets

BR Varga, JM Streicher… - British journal of …, 2023 - Wiley Online Library
Opioids continue to be of use for the treatment of pain. Most clinically used analgesics target
the μ opioid receptor whose activation results in adverse effects like respiratory depression …

Biased mu-opioid receptor ligands: a promising new generation of pain therapeutics

ER Siuda, R Carr III, DH Rominger, JD Violin - Current opinion in …, 2017 - Elsevier
Highlights•Biased MOR ligands discovered using empirical, rational and natural product
approaches.•Biased MOR ligands produce analgesia with fewer side effects in mice and …

Basic opioid pharmacology: an update

H Pathan, J Williams - British journal of pain, 2012 - journals.sagepub.com
Opioids are a group of analgesic agents commonly used in clinical practice. There are three
classical opioid receptors (DOP, KOP and MOP), while the novel NOP receptor is …